NLRP3 and pulmonary fibrosis: The activation of NLRP3 is increased in pulmonary fibrosis, and inhibition of NLRP3 can effectively delay the progression of pulmonary fibrosis, indicating that targeted NLRP3 may be a new choice for the treatment of pulmonary fibrosis.